8-K current report · filed Jul 28, 2026

Core Scientific, Inc./tx (CORZ) 8-K Current Report: July 28, 2026

Item 2.02Item EX-99.1Item EX-99.2Item 7.01CORZ overview

Short answer

Core Scientific, Inc./tx (CORZ) filed an 8-K current report with the SEC on July 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2), Item 7.01 (Regulation FD Disclosure). Core Scientific announced second-quarter fiscal 2026 results for the period ended June 30, 2026.

Core Scientific, Inc./tx 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Core Scientific announced second-quarter fiscal 2026 results for the period ended June 30, 2026
  • Financial details and management commentary are contained in Exhibit 99.1, the accompanying earnings release

Item EX-99.1 · Exhibit EX-99.1

  • AMD partnership supports up to 2.5 GW, including 530 MW under 15-year agreements and more than $14B potential base contracted revenue
  • Leased customer capacity reached approximately 1.1 GW, representing more than $24B potential contracted revenue
  • Q2 revenue $164.2M, colocation revenue $136.7M, and Adjusted EBITDA $41.1M versus $8.9M in Q1
  • Colocation gross margin improved to 59% from 57% in Q1 and 11% in Q2 2025
  • Net loss $1.155B, primarily reflecting a $1.046B warrant fair-value loss, while CapEx reached $797.5M

Item EX-99.2 · Exhibit EX-99.2

  • AI colocation platform supporting 1.1 GW across 7 states, with $24B+ contracted revenue and ~$1.8B average annualized colocation revenue
  • CoreWeave contracts cover ~590 MW, $10B+ potential revenue, and ~$850M average annualized GAAP revenue
  • CoreWeave buildout substantially complete, with over 430 MW billing by mid-July and remaining delivery expected by early 2027
  • AMD relationship targets 530 MW delivered by end-2028, with initial capacity expected in 1H 2027
  • Pro forma diluted share count ~508 million, creating a key dilution consideration for valuation and per-share returns

Other items in this filing:

  • Item 7.01: Regulation FD Disclosure

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Core Scientific, Inc./tx 8-K filings

Get the next CORZ 8-K as it lands

Follow CORZ for push alerts, or ask the research agent what this filing means.